{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:46:19Z","timestamp":1793252779800,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Iberoamericana de Micolog\u00eda"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.riam.2014.07.006","type":"journal-article","created":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T01:08:56Z","timestamp":1417309736000},"page":"214-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Response to therapy in patients with cryptococcosis and AIDS: Association with in vitro susceptibility to fluconazole"],"prefix":"10.1016","volume":"32","author":[{"given":"Carlos Andr\u00e9s","family":"Agudelo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Mar\u00eda","family":"Tob\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"de Bedout Bact","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz Elena","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Restrepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.riam.2014.07.006_bib0005","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1128\/AAC.44.6.1544-1548.2000","article-title":"Correlation of fluconazole MIC with clinical outcome in cryptococcal infection","volume":"44","author":"Aller","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2014.07.006_bib0010","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s100960100616","article-title":"Cryptococcus neoformans infection in a cohort of Italian AIDS patients: natural history, early prognostic parameters, and autopsy findings","volume":"20","author":"Antinori","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.riam.2014.07.006_bib0015","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.riam.2009.02.001","article-title":"Fluconazole and amphotericin B susceptibility testing of Cryptococcus neoformans: results of minimal inhibitory concentrations against 265 isolates from HIV-positive patients before and after two or more months of antifungal therapy","volume":"26","author":"Arechavala","year":"2009","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.riam.2014.07.006_bib0020","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1128\/JCM.34.9.2154-2157.1996","article-title":"Fluconazole disk diffusion procedure for determining susceptibility of Candida species","volume":"34","author":"Barry","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.riam.2014.07.006_bib0025","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1086\/507895","article-title":"Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution","volume":"43","author":"Bicanic","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2014.07.006_bib0030","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jinf.2008.06.020","article-title":"Treatment of cryptococcal meningitis in Peruvian AIDS patients using amphotericin B and fluconazole","volume":"57","author":"Dammert","year":"2008","journal-title":"J Infect"},{"key":"10.1016\/j.riam.2014.07.006_bib0035","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1128\/AAC.01520-05","article-title":"Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis","volume":"50","author":"Dannaoui","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2014.07.006_bib0040","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1128\/AAC.01115-12","article-title":"Cryptococcus neoformans\u2013Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole","volume":"56","author":"Espinel-Ingroff","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2014.07.006_bib0045","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00002030-200205030-00009","article-title":"Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults","volume":"16","author":"French","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.riam.2014.07.006_bib0050","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1128\/JCM.36.10.2874-2876.1998","article-title":"Fluconazole susceptibility testing of Cryptococcus neoformans: comparison of two broth microdilution methods and clinical correlates among isolates from Ugandan AIDS patients","volume":"36","author":"Jessup","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.riam.2014.07.006_bib0055","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1128\/AAC.49.8.3297-3301.2005","article-title":"Correspondence of in vitro and in vivo fluconazole dose-response curves for Cryptococcus neoformans","volume":"49","author":"Larsen","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2014.07.006_bib0060","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7705\/biomedica.v27i1.236","article-title":"Grupo Colombiano para el estudio de la Criptococosis: results of nine years of the clinical and epidemiological survey on cryptococcosis in Colombia, 1997\u20132005","volume":"27","author":"Lizarazo","year":"2007","journal-title":"Biom\u00e9dica"},{"key":"10.1016\/j.riam.2014.07.006_bib0065","series-title":"Method for antifungal disk diffusion susceptibility testing of yeast. Proposed guideline M44-A","author":"National Committee for Clinical Laboratory Standards","year":"2004"},{"key":"10.1016\/j.riam.2014.07.006_bib0070","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeast. Approved standard M27-A2","author":"National Committee for Clinical Laboratory Standards","year":"2002"},{"key":"10.1016\/j.riam.2014.07.006_bib0075","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1086\/649861","article-title":"Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi","volume":"50","author":"Nussbaum","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2014.07.006_bib0080","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1086\/599112","article-title":"A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2014.07.006_bib0085","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2014.07.006_bib0090","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/JCM.01747-08","article-title":"Results from the ARTEMIS DISK global antifungal surveillance study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and Voriconazole determined by CLSI Standardized Disk Diffusion Testing","volume":"47","author":"Pfaller","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.riam.2014.07.006_bib0095","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1086\/342384","article-title":"Has antifungal susceptibility testing come of age?","volume":"35","author":"Rex","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2014.07.006_bib0100","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/515110","article-title":"A comparison of itraconazol versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis","volume":"28","author":"Saag","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2014.07.006_bib0105","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/313757","article-title":"Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America","volume":"30","author":"Saag","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2014.07.006_bib0110","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/jac\/dkh361","article-title":"Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002","volume":"54","author":"Sar","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.riam.2014.07.006_bib0115","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/clinids\/22.2.322","article-title":"Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing","volume":"22","author":"Witt","year":"1996","journal-title":"Clin Infect Dis"}],"container-title":["Revista Iberoamericana de Micolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130140614000862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130140614000862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T09:51:31Z","timestamp":1598521891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130140614000862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1130140614000862"],"URL":"https:\/\/doi.org\/10.1016\/j.riam.2014.07.006","relation":{},"ISSN":["1130-1406"],"issn-type":[{"value":"1130-1406","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Response to therapy in patients with cryptococcosis and AIDS: Association with in vitro susceptibility to fluconazole","name":"articletitle","label":"Article Title"},{"value":"Revista Iberoamericana de Micolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.riam.2014.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Revista Iberoamericana de Micolog\u00eda. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}